Detailed information for compound 1806917

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 298.336 | Formula: C17H18N2O3
  • H donors: 1 H acceptors: 1 LogP: 3.13 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CO/N=C(/c1ccccc1COc1ccccc1)\C(=O)NC
  • InChi: 1S/C17H18N2O3/c1-18-17(20)16(19-21-2)15-11-7-6-8-13(15)12-22-14-9-4-3-5-10-14/h3-11H,12H2,1-2H3,(H,18,20)/b19-16-
  • InChiKey: KYPNOVKXLBXRJL-MNDPQUGUSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.0687 0.9094 0.5
Schistosoma mansoni tyrosine kinase 0.0733 1 1
Toxoplasma gondii proteasome subunit beta type, putative 0.0687 0.9094 0.5
Trypanosoma brucei proteasome subunit beta type-5, putative 0.0687 0.9094 0.5
Entamoeba histolytica proteasome subunit beta type 5 precursor, putative 0.0687 0.9094 0.5
Schistosoma mansoni proteasome catalytic subunit 3 (T01 family) 0.0687 0.9094 0.908
Mycobacterium tuberculosis Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. 0.0687 0.9094 0.5
Echinococcus multilocularis insulin receptor 0.0234 0.0145 0.0145
Leishmania major proteasome beta 5 subunit, putative 0.0687 0.9094 0.5
Schistosoma mansoni tyrosine kinase 0.039 0.3217 0.3117
Echinococcus granulosus proteasome prosome macropain 0.0687 0.9094 0.908
Echinococcus granulosus epidermal growth factor receptor 0.0394 0.3299 0.32
Echinococcus multilocularis insulin growth factor 1 receptor beta 0.0234 0.0145 0.0145
Mycobacterium leprae proteasome (beta subunit) PrcB 0.0687 0.9094 0.5
Plasmodium vivax proteasome subunit beta type-5, putative 0.0687 0.9094 0.5
Loa Loa (eye worm) proteasome A-type and B-type family protein 0.0687 0.9094 0.908
Schistosoma mansoni tyrosine kinase 0.039 0.3217 0.3117
Echinococcus multilocularis epidermal growth factor receptor 0.0394 0.3299 0.3299
Mycobacterium ulcerans proteasome PrcB 0.0687 0.9094 0.5
Echinococcus multilocularis epidermal growth factor receptor 0.0733 1 1
Echinococcus multilocularis proteasome (prosome, macropain) 0.0687 0.9094 0.9094
Schistosoma mansoni tyrosine kinase 0.0394 0.3299 0.32
Trypanosoma cruzi proteasome subunit beta type-5, putative 0.0687 0.9094 0.5
Schistosoma mansoni tyrosine kinase 0.0394 0.3299 0.32
Trichomonas vaginalis Family T1, proteasome beta subunit, threonine peptidase 0.0687 0.9094 0.5
Schistosoma mansoni tyrosine kinase 0.039 0.3217 0.3117
Plasmodium falciparum proteasome subunit beta type-5 0.0687 0.9094 0.5
Echinococcus granulosus melanoma receptor tyrosine protein kinase 0.0394 0.3299 0.32
Echinococcus granulosus epidermal growth factor receptor 0.0733 1 1
Giardia lamblia Proteasome subunit beta type 5 precursor 0.0687 0.9094 0.5
Brugia malayi Proteasome A-type and B-type family protein 0.0687 0.9094 0.908
Loa Loa (eye worm) TK/EGFR protein kinase 0.0733 1 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.